Unknown

Dataset Information

0

Innate T-?? lymphocytes as new immunological components of anti-tumoral "off-target" effects of the tyrosine kinase inhibitor dasatinib.


ABSTRACT: Kinase inhibitors hold great potential as targeted therapy against malignant cells. Among them, the tyrosine kinase inhibitor dasatinib is known for a number of clinically relevant off-target actions, attributed in part to effects on components of the immune system, especially conventional T-cells and natural killer (NK)-cells. Here, we have hypothesized that dasatinib also influences non-conventional T-?? cell subsets known for their potential anti-tumoral properties, namely iNKT cells and the distinct new innate CD8 T-cell subset. In mice, where the two subsets were originally characterized, an activated state of iNKT cells associated with a shift toward an iNKT cell Th1-phenotype was observed after dasatinib treatment in vivo. Despite decreased frequency of the total memory CD8 T-cell compartment, the proportion of innate-memory CD8 T-cells and their IFN? expression in response to an innate-like stimulation increased in response to dasatinib. Lastly, in patients administered with dasatinib for the treatment of BCR-ABL-positive leukemias, we provided the proof of concept that the kinase inhibitor also influences the two innate T-cell subsets in humans, as attested by their increased frequency in the peripheral blood. These data highlight the potential immunostimulatory capacity of dasatinib on innate T-?? cells, thereby opening new opportunities for chemoimmunotherapy.

SUBMITTER: Barbarin A 

PROVIDER: S-EPMC7039999 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC5237805 | BioStudies
2020-01-01 | S-EPMC6985454 | BioStudies
2019-01-01 | S-EPMC6424602 | BioStudies
1000-01-01 | S-EPMC3681879 | BioStudies
2017-01-01 | S-EPMC5366313 | BioStudies
2015-01-01 | S-EPMC4530047 | BioStudies
2019-01-01 | S-EPMC6926036 | BioStudies
2013-01-01 | S-EPMC3824254 | BioStudies
2013-01-01 | S-EPMC3805549 | BioStudies
2019-01-01 | S-EPMC6803753 | BioStudies